Age is independently associated with pulmonary arterial compliance in health and in patients with pulmonary vascular disease

Andy Swift (Sheffield, United Kingdom), Andy Swift, Angela Lungu, Dave Capener, Charlotte Hammerton, Alex Rothman, Allan Lawrie, Charlie Elliot, Robin Condliffe, David Kiely, Jim Wild

Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Session: Pulmonary hypertension: exercise, haemodynamics, and physiology
Session type: Thematic Poster
Number: 2426
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Andy Swift (Sheffield, United Kingdom), Andy Swift, Angela Lungu, Dave Capener, Charlotte Hammerton, Alex Rothman, Allan Lawrie, Charlie Elliot, Robin Condliffe, David Kiely, Jim Wild. Age is independently associated with pulmonary arterial compliance in health and in patients with pulmonary vascular disease. Eur Respir J 2016; 48: Suppl. 60, 2426

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


Baseline hemodynamic predictors of treatment response in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Myocardial perfusion in patients with pulmonary hypertension of different etiology
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015


CT measured pulmonary artery to aorta ratio as a predictor of pulmonary hypertension in COPD
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


PAH-specific therapies improve survival in patients with pulmonary arterial hypertension associated with connective tissue diseases: A Russian single centre experience
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014

Sildenafil improves heart rate variability, pulmonary hemodynamics and functional status in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Hemodynamic assessment of patients with pulmonary hypertension due to lung disease and/or hypoxia
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

Limited and heterogeneous arterial narrowing in idiopathic pulmonary hypertension: Rethinking resistance
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015

Pulmonary vascular reactivity in pulmonary hypertension due to left heart disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Cardiopulmonary comorbidities are associated with hemodynamics in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015


Gender differences in right-ventricular arterial coupling in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

About cardiac output assessment in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Impact of borderline pulmonary arterial pressure on survival
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016

MRI-derived regional pulmonary perfusion and cardiac function for monitoring patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy
Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment
Year: 2015


The different nature of pulmonary vascular resistant and compliance in reduced and preserved ejection fraction heart failure and associated pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014


Mitomycin-induced pulmonary veno-occlusive disease: Experience from the French pulmonary hypertension network
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015


HbA1c-levels in patients with operable chronic thromboembolic pulmonary hypertension
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014